tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

JAF Capital Pty Ltd Ceases Substantial Holding in Hydration Pharmaceuticals

Story Highlights
  • JAF Capital Pty Ltd no longer holds a substantial stake in Hydration Pharmaceuticals.
  • An on-market sale of over 2 million securities may affect the company’s shareholder structure.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
JAF Capital Pty Ltd Ceases Substantial Holding in Hydration Pharmaceuticals

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Hydration Pharmaceuticals Co. Ltd. ( (AU:HPC) ) has provided an update.

Hydration Pharmaceuticals Co. Ltd. has announced that JAF Capital Pty Ltd has ceased to be a substantial holder in the company as of October 6, 2025. This change involved an on-market sale of 2,049,263 voting securities, valued at $25,291.01, which may impact the company’s shareholder structure and influence in the market.

More about Hydration Pharmaceuticals Co. Ltd.

Average Trading Volume: 1,220,826

Technical Sentiment Signal: Sell

Current Market Cap: A$5.6M

For an in-depth examination of HPC stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1